Your browser doesn't support javascript.
loading
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study.
Raghu, Ganesh; Hamblin, Mark J; Brown, A Whitney; Golden, Jeffrey A; Ho, Lawrence A; Wijsenbeek, Marlies S; Vasakova, Martina; Pesci, Alberto; Antin-Ozerkis, Danielle E; Meyer, Keith C; Kreuter, Michael; Burgess, Tracy; Kamath, Nikhil; Donaldson, Francis; Richeldi, Luca.
Afiliação
  • Raghu G; Center for Interstitial Lung Diseases, Department of Medicine and Laboratory Medicine, University of Washington, Seattle, WA, USA. graghu@uw.edu.
  • Hamblin MJ; Pulmonary and Critical Care Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
  • Brown AW; Inova Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, VA, USA.
  • Golden JA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Ho LA; Center for Interstitial Lung Diseases, Department of Medicine and Laboratory Medicine, University of Washington, Seattle, WA, USA.
  • Wijsenbeek MS; Department of Respiratory Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
  • Vasakova M; Department of Respiratory Medicine, First Faculty of Medicine of Charles University and Thomayer Hospital, Prague, Czech Republic.
  • Pesci A; School of Medicine and Surgery, University of Milano-Bicocca, ASST-Monza, Milano, Italy.
  • Antin-Ozerkis DE; Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Meyer KC; Department of Medicine, Division of Pulmonary and Critical Care, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Kreuter M; Center for Interstitial and Rare Lung Diseases, Department of Pneumology, Thoraxklinik, University of Heidelberg and German Center for Lung Research, Heidelberg, Germany.
  • Burgess T; Genentech, Inc., South San Francisco, CA, USA.
  • Kamath N; Roche Products Ltd., Welwyn Garden City, UK.
  • Donaldson F; Roche Products Ltd., Welwyn Garden City, UK.
  • Richeldi L; Fondazione Policlinico Universitario A Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Respir Res ; 23(1): 129, 2022 May 21.
Article em En | MEDLINE | ID: mdl-35597980
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Fibrose Pulmonar Idiopática Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Respir Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Fibrose Pulmonar Idiopática Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Respir Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos